What are the causes of endobronchial nodules?

Causes of Endobronchial Nodules

Endobronchial nodules are most commonly caused by malignancy (primary lung cancer or metastatic disease) and tuberculosis granulomas, which together account for approximately 70% of cases with definitive pathological diagnosis. 1

Primary Malignant Causes

Primary lung cancer represents the single most important malignant etiology, particularly early-stage squamous cell carcinoma and adenocarcinoma confined to the central airways. 2

• Squamous cell carcinoma is the predominant histologic type in early central lung cancers, accounting for over 97% of lesions amenable to endobronchial therapy. 2
• Endobronchial appearance correlates with depth of invasion: small hypertrophic lesions (superficial thickening <10 mm diameter) invade beyond cartilage in only 5% of cases, while nodular lesions (elevation ≥2 mm with large base) and polypoid lesions invade beyond cartilage in 18% and 27% respectively. 2
• Malignant endobronchial nodules typically appear pale and smaller compared to benign granulomatous lesions. 1

Metastatic Disease

Endobronchial metastases from extrapulmonary solid tumors account for approximately 4% of all bronchoscopic biopsies performed for suspected malignancy. 3

• Breast cancer (30%), colorectal cancer (24%), renal cell carcinoma (14%), gastric cancer (6%), prostate cancer (4.5%), and melanoma (4.5%) are the most common primary tumors metastasizing to the endobronchial tree. 3
• In 5% of cases, the endobronchial metastasis is the first manifestation of an occult extrapulmonary malignancy (anachronous presentation). 3
• Mean latency from primary tumor diagnosis to endobronchial metastasis is 136 months (range 1-300 months), with 89% presenting metachronously. 3

Infectious Causes

Tuberculosis granulomas represent 29% of endobronchial nodules with definitive pathological diagnosis, making TB the most common benign cause. 1

• TB granulomas typically present as larger nodules with smooth, intact mucosa, contrasting with the pale, smaller appearance of malignant lesions. 1
• Aspergillosis causes endobronchial lesions particularly in immunosuppressed patients, with significantly higher incidence in this population (P=0.0001) and the poorest prognosis among benign lesions regardless of immune status. 4
• Endemic mycoses (histoplasmosis, coccidioidomycosis, blastomycosis) commonly cause pulmonary nodules that can present endobronchially and may show increased metabolic activity on PET scan even without active symptoms. 5

Inflammatory and Granulomatous Conditions

Sarcoidosis accounts for 3.6% of endobronchial nodules and produces granulomatous inflammation that can cause false-positive PET scan results. 1, 5

• Tracheobronchopathia osteochondroplastica represents 21.8% of cases, characterized by multiple submucosal cartilaginous and osseous nodules. 1
• Chronic inflammation of unknown etiology was found in 32 cases without specific pathological diagnosis beyond granuloma formation. 1

Rare Benign Causes

Benign tumors and miscellaneous lesions account for a small proportion of endobronchial nodules:

• Hamartomas are characterized by intranodular fat and "popcorn" calcification, though these typically present as parenchymal rather than endobronchial lesions. 5
• Foreign body aspiration can mimic endobronchial tumors, particularly in adults where aspiration is less commonly suspected; these may present with complications including pneumothorax. 6
• Lymphoma rarely presents as endobronchial nodules (1.8% of cases). 1

Clinical Presentation and Diagnostic Approach

The majority of patients (26%) with endobronchial nodules are asymptomatic, while symptomatic patients most commonly present with dyspnea (23%), cough (15%), and hemoptysis (12%). 3

• If endobronchial nodules are suspected on imaging, repeat LDCT after 1 month is recommended following vigorous coughing to distinguish true endobronchial lesions from mobile secretions. 2
• There is no consistent relationship between nodule distribution pattern and pathological diagnosis, requiring tissue sampling for definitive diagnosis. 1
• Biopsy should be performed for all endobronchial nodules, as pathology results of TB, sarcoidosis, and fungal infection may initially show only granuloma of unknown reason, requiring additional clinical correlation. 1

Critical Diagnostic Pitfall

One-fifth of benign endobronchial lesions cause critical airway stenosis >50%, most frequently in tuberculosis (P=0.031) and aspergillosis (P=0.020), requiring rigid bronchoscopy and therapeutic intervention. 4 This underscores that even when malignancy is excluded, aggressive management may be necessary to prevent respiratory compromise.